Express Pharma

APRIL 30, 2025

KPMG International has released its latest findings from the KPMG global tech report: Life sciences insights , highlighting how organisations in the life sciences sector are approaching digital transformation, technology investment, data strategy, AI integration, and cyber security. The report draws insights from the KPMG global tech report 2024 , which surveyed 2,450 technology leaders across 26 countries and eight industries.

85

85

PharmaVoice

APRIL 30, 2025

A leaked document revealed details about changes that could impact how the agency operates, but recent comments from FDA Commissioner Dr. Marty Makary have muddied the picture.

Documentation 147

Documentation 147

Express Pharma

APRIL 30, 2025

Effective project management is vital in any manufacturing environment particularly where stringent regulations and intricate production processes are involved. As a Contract Development and Manufacturing Organisation (CDMO), companies such as Bachem play a crucial role in supplying Active Pharmaceutical Ingredients (APIs) to biotech and pharmaceutical companies, with responsibilities including raw materials management, process development and validation, production, purification, and delivery.

Communication 85

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 85

STAT

APRIL 30, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, let’s get into all the updates from a busy earnings season so far.

Drug Pricing 147

Drug Pricing Drug Development 147

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Express Pharma

APRIL 30, 2025

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval from the United States Food and Drug Administration (USFDA) for Celecoxib Capsules in strengths of 100 mg, 200 mg, and 400 mg. According to Strides, the product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Celebrex Capsules, in the same strengths, which is marketed by Upjohn US 2 LLC.

66

66

Drug Patent Watch

APRIL 30, 2025

"Game Changers in Generic Drug Development: What's Next? As the pharmaceutical industry continues to evolve, one thing is clear: the future of generic drug development is about to get a whole lot more interesting. I recently came across an article that caught my eye: "The Future of Generic Drug Development: Emerging Technologies and Approaches" from @DrugPatentWatch.

Drug Development 65

Drug Development 65

Pharma Marketing Network

APRIL 30, 2025

Table of Contents Understanding the Pharma Research Landscape Leveraging Patient Influencers in Research Utilizing Digital Tools and Platforms Strategic Steps to Initiate Pharma Research Conclusion FAQs Understanding the Pharma Research Landscape Embarking on pharma research can seem daunting, especially with the industry’s rapid evolution. However, understanding the current landscape is crucial for effective marketing strategies.

52

52

Big Molecule Watch

APRIL 30, 2025

This week, CuraTeQ Biologics (a wholly owned step-down subsidiary of Aurobindo Pharma Limited) announced that its trastuzumab biosimilar, DAZUBLYS, has received a positive opinion from the European Medicines Agency Committee for Medicinal Products for Human Use (CHMP). DAZUBLYS, a 150 mg powder for concentrate for solution for infusion product, specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein as a treatment for certain solid cancers, such as breast and

Biosimilars 52

Biosimilars 52

pharmaphorum

APRIL 30, 2025

Novartis has grown in renal diseases once again with a $1.

Drug Development 92

Drug Development 92

Pharma Times

APRIL 30, 2025

Study paves the way for personalised therapies for osteoarthritis sufferer

88

88

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

APRIL 30, 2025

Driving innovation and improving patient outcomes through inclusive medical research Nicole.

86

86

World Pharma News

APRIL 30, 2025

Novartis today announced that it has entered into an agreement to acquire Regulus Therapeutics, a San Diego-based, publicly traded (Nasdaq: RGLS) clinical-stage biopharmaceutical company focused on developing microRNA therapeutics. Regulus' lead asset, farabursen, is a potential first-in-class, next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

86

86

Pharma Times

APRIL 30, 2025

New therapy offers hope for patients with limited option

86

86

pharmaphorum

APRIL 30, 2025

GSK has said it is not too worried about the impact of potential pharma-specific US tariff rules as it posts a solid set of first-quarter results.

69

69

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmaceutical Commerce

APRIL 30, 2025

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and hybrid technology models.

Specialty Pharmacies 69

Specialty Pharmacies 69

Pharmacy Times

APRIL 30, 2025

Research reveals that children face significant long-term health risks, including kidney, gastrointestinal, and cardiovascular issues, after COVID-19 infection.

67

67

BioPharma Dive

APRIL 30, 2025

In its first full quarter, Attruby made more headway than analysts anticipated in its competition with Pfizer’s market-leading drug.

67

67

pharmaphorum

APRIL 30, 2025

AstraZeneca has said it is considering a shift in the production of some medicines from Europe to the US in order to sidestep potential tariffs

66

66

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

APRIL 30, 2025

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance microRNA technology.

62

62

pharmaphorum

APRIL 30, 2025

Novo Nordisk has enlisted the aid of major telehealth companies as it tries to dominate the self-pay market for obesity drugs in the US

66

66

Pharmaceutical Technology

APRIL 30, 2025

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease market.

59

59

pharmaphorum

APRIL 30, 2025

Abeona Therapeutics' Zevaskyn has been approved in the US as a treatment for the rare skin disorder recessive dystrophic epidermolysis bullosa (DEB)

59

59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

APRIL 30, 2025

The company has predicted that Imaavy — now approved for generalized myasthenia gravis — could eventually earn more than $5 billion in annual sales at its peak.

Immunization 53

Immunization Immunity 53

PharmaTech

APRIL 30, 2025

Webinar Date/Time: Thu, May 22, 2025 11:00 AM EDT

Dosage 52

Dosage 52

Pharmacy Joe

APRIL 30, 2025

In this episode, Ill discuss animal data on the rate of correction for acute hypernatremia. Episode 1022: Can Animal Data Inform the Ideal Rate of Correction for Acute Hypernatremia? Subscribe on iTunes , Android , or Stitcher Acute hypernatremia is a common occurrence in ICU patients. Whenever there is an acute and significant change in sodium levels – whether high or low – there is concern about the safe speed of correction to avoid adverse neurological effects.

Hospitals 52

Hospitals Inpatient 52

PharmExec

APRIL 30, 2025

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and hybrid technology models.

Specialty Pharmacies 52

Specialty Pharmacies 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Commerce

APRIL 30, 2025

Amy Niles, chief mission officer, PAN Foundation, discusses the latest changes to the Medicare program that have the potential to improve patient access to care, along with the work needed to generate awareness about them.

52

52

PharmExec

APRIL 30, 2025

Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.

52

52

Pharmaceutical Commerce

APRIL 30, 2025

Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.

52

52

PharmaTech

APRIL 30, 2025

Bempikibart (ADX-914) is a human anti-IL-7R antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management